Items tagged with Advocacy
Letter to Sanofi calling for patent withdrawals on critical TB drugs (post with simple image)
TAG and OTMeds call on Sanofi to reverse its efforts to patent two obvious combinations of two critical drugs to prevent TB: rifapentine and isoniazid.
Declaration of the Rights of People Affected by TB now available in Arabic (post with simple image)
The Declaration was launched in May 2019 by TBpeople in partnership with the Stop TB Partnership.
TAG policy brief: TB Research Investments Provide Returns in Combating Both TB and COVID-19 (post with simple image)
Sustained and expanded financing is needed to safeguard TB research against COVID-19–related disruptions and improve global epidemic preparedness.
TAG policy brief: Advancing Access through Market Interventions (post with simple image)
Lessons Learned from the GeneXpert Tuberculosis Test Buy-Down
Public investment in bedaquiline up to five-fold that of Johnson & Johnson (post with simple image)
PLOS ONE publishes TAG’s rigorous, peer-reviewed calculation of investments in the development of this life-saving TB medicine.
Policy brief: COVID-19 – the new reality of Ending Tuberculosis (post with simple image)
A document, released by the TB Europe Coalition, in commemoration of the second anniversary of the signing of the UN Political Declaration on TB.
New survey finds millions of people affected by TB still diagnosed and treated with outdated tools (post with simple image)
Data on 37 countries reveals widespread failure to follow latest international recommendations for policies on prevention, diagnosis, and treatment.
Paediatric HIV & TB: Rome Action Plan (post with simple image)
EGPAF, WHO, PEPFAR, UNAIDS, Stop TB Partnership and FBOs: World Children’s Day statement on advances in access to paediatric HIV and TB diagnosis and treatments
New TAG report: Funding for TB research in 2019 nears half of global target (post with simple image)
The report — Tuberculosis Research Funding Trends, 2005–2019 — presents new data on 2019 funding for TB research and development and analyzes trends in investment since 2005.
Page 91 of 92 · Total posts: 0←First 90 91 92 Last→